The 030-Lab is a core-facility in the Wilhelmina Children’s Hospital where researchers from all disciplines in the UMC Utrecht, Utrecht University and the Princess Máxima Center work closely together. The goal of  the 030-Lab is to perform innovative research which will improve the treatment of diseases and the quality of life of children and adolescents and to reduce health damage.

Innovative trials

The 030-Lab Innovative trial office supports Child Health researchers with the design and conduct of studies. Researchers here conduct clinical research into new innovative treatments, like stem cell therapy, mRNA therapy or gene therapy. They also investigate how existing treatments can be improved. Research is being conducted on the treatment of many rare diseases, like cystic fibrosis, infectious diseases, juvenile rheumatism, rare metabolic diseases, neonatal diseases and many others. These studies are initiated by researchers (investigator initiated) or by a sponsor (industry sponsored trials).

About us

The Innovative trial office has up-to-date knowledge, extensive experience and supports researchers in the grant application, design, conduct and coordination of studies. This may involve clinical (phase 1 to 4), observational and translational research. The Innovative trial office also provides professional support for locally initiated trials and large, complex multicenter studies.